Nutrimed Biotech

Rheonix Inc, based in Ithaca, NY, is a leading provider of innovative molecular testing solutions for various industries, including food and beverage, clinical research, and diagnostics. Their Encompass family of workstations offers fully automated and integrated devices that deliver efficient and cost-effective molecular testing with multiplexing capabilities. Rheonix's cutting-edge technology enables low-level detection of pathogens, such as Listeria and Cyclospora, in food and environmental samples, helping food producers identify and mitigate recurring issues in their facilities. With a focus on open and adaptable products, Rheonix empowers laboratories to develop customized assays for testing foods and beverages. Their commitment to providing reliable and accurate testing solutions has made them a trusted partner for laboratories worldwide. Rheonix's dedication to innovation and customer satisfaction has positioned them as a leader in the field, offering comprehensive testing solutions for a wide range of industries.Generated from the website

Boyce Thompson Institute (BTI) is a renowned research institution in Ithaca, NY, dedicated to advancing plant science and its applications for the betterment of society. With a team of esteemed faculty and state-of-the-art facilities, BTI conducts cutting-edge research in various areas, including plant evolution, defense mechanisms, and computational biology, aiming to unravel the mysteries of plant life and harness their potential for the benefit of humanity.Generated from the website

Cell Preservation Service Inc (CPSI Biotech) is a leading company based in Owego, NY, specializing in the development of novel technologies and innovative life science research products. With a diverse team of dedicated professionals, CPSI Biotech focuses on designing cryo-medical devices and preservation technologies for applications in cancer, cardiovascular disease treatments, and cell therapy bioprocessing. Their mission is to challenge the current scientific dogma and advance both basic and clinical sciences. CPSI Biotech's success lies in their integrative approach and the expertise of their team, which enables them to develop cutting-edge cryoablation and preservation technologies. Their range of investigational devices is aimed at revolutionizing the field of life sciences, with a particular emphasis on cancer treatment, cardiovascular disease, and cell therapy. CPSI Biotech is committed to pushing the boundaries of scientific discovery and partnering with researchers and innovators to drive advancements in the field.Generated from the website